Senti Biosciences Holdings SNTI Cash Flow Statement (2021-2026)

NASDAQ SNTI
$0.30 -0.02 (-5.38%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Senti Biosciences Holdings Quarterly Cash Flow Statement

Periods 21 quarters
Latest Jun 2026

Senti Biosciences Holdings cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 21 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-8.99M-11.42M-3.86M-11.75M-21.74M-16.54M-24.21M-18.77M-18.84M-21.60M-18.30M-15.97M-13.12M-15.06M-15.94M-16.00M-16.53M-16.78M-18.54M-14.43M
Share-based Compensation
0.63M0.73M0.66M9.22M2.29M4.22M3.76M3.43M-2.00M2.06M1.26M-0.78M0.67M0.60M1.20M1.53M1.55M1.43M
Gains from Investment Securities
-8.88M0.10M-0.72M-0.06M-0.15M-0.02M
Asset Writedowns and Impairment
25.69M0.26M0.30M5.10M
Cash from Operations
-0.93M-1.05M-1.14M-10.06M-5.70M-10.14M-9.01M-16.30M-13.68M-15.38M-7.04M-11.68M-8.35M-7.87M-13.50M-14.05M-13.07M-9.45M-6.88M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.68M0.81M0.77M0.66M0.59M0.49M0.57M0.38M0.43M0.48M0.48M0.50M0.52M0.52M
Change in Working Capital
Change in Receivables
0.05M-0.05M0.14M0.27M-0.23M0.14M-0.20M2.67M-1.17M-0.04M0.19M-0.02M0.53M0.45M1.43M-1.93M-0.33M
Change in Account Payables
0.00M85.00-2.33M-0.16M0.40M-0.14M0.09M0.28M0.60M-0.42M-0.76M0.39M-0.44M-0.39M1.24M0.36M-0.54M0.75M1.17M
Change in Accured Expenses
0.00M0.03M3.08M-1.41M1.62M1.28M0.57M-1.85M-0.24M0.89M1.91M-2.95M-0.17M0.42M2.03M-1.12M-0.05M1.48M0.25M
Other Working Capital Changes
0.80M0.06M2.42M5.52M3.22M2.97M0.88M0.15M-0.92M0.37M-0.95M-0.98M-1.03M-1.07M-1.09M-1.13M-1.19M-1.23M
Investing Activities
Capital Expenditures
0.93M3.98M8.92M9.72M14.20M8.53M6.51M3.67M1.86M0.00M0.01M0.01M0.17M0.03M
Sales of Property, Plant and Equipment
0.10M0.06M
Change in Acquisitions & Divestments
15.00M22.00M23.00M
Cash from Investing Activities
-230.00M-230.00M-230.00M-7.38M-11.26M-14.20M-49.12M-9.50M18.33M21.14M0.10M-0.01M0.06M-0.01M-0.18M
Financing Activities
Other financing activities
225.40M225.40M225.40M0.14M112.32M-0.48M-0.00M0.38M2.43M44.82M1.51M1.01M0.53M
Debt Issuance and Repayment
Long-Term Debt Issuances
0.25M0.25M0.25M
Change in Capital Stock
Net Equity Issued and Repurchased
0.73M0.20M0.01M1.80M0.14M10.51M
Misc.
Cash from Financing Activities
232.03M232.03M232.03M-0.46M118.61M-0.48M0.88M-0.04M0.28M-0.02M0.56M2.44M51.29M-0.41M1.01M0.12M11.04M
Change in Cash
1.10M0.98M0.89M-17.89M101.66M-24.82M-57.25M-25.84M4.94M5.74M-6.38M-11.70M-8.35M-5.37M37.77M-14.46M-12.25M-9.32M4.17M
Free Cash Flow
-0.93M-1.98M-5.13M-18.98M-15.41M-24.34M-17.54M-22.81M-17.34M-17.24M-7.04M-11.70M-8.35M-7.87M-13.52M-14.22M-13.10M-9.45M-6.88M
Net Cash Flow
1.10M0.98M0.89M-17.89M101.66M-24.82M-57.25M-25.84M4.94M5.74M-6.38M-11.70M-8.35M-5.37M37.77M-14.46M-12.25M-9.32M4.17M